FDA Recalls Better Weather Fix Elixir for Undeclared Kratom Alkaloids

On May 11, 2026, the FDA announced a recall of Better Weather Fix Elixir dietary supplements manufactured by XD Investments LLC due to the presence of undeclared mitragynine and mitragynine pseudoindoxyl—active alkaloids derived from kratom. The recall, listed as Class II on the FDA's official recalls database, highlights a critical gap in supplement labeling practices that can expose consumers to unexpected pharmacological effects and serious drug interactions. Undeclared active ingredients pose unpredictable health risks, especially for individuals taking medications or managing chronic conditions. This action underscores the FDA's ongoing effort to protect consumers from mislabeled dietary supplement products.

What happened

According to the FDA's recalls database, XD Investments LLC initiated the recall of Better Weather Fix Elixir dietary supplements because the products contain mitragynine and mitragynine pseudoindoxyl that were not declared on the label. The recall was formally listed on May 11, 2026, and represents a Class II-level safety concern. Consumers who have purchased these supplements should discontinue use immediately and return the product to the place of purchase for a refund.

The recall notification was posted on the FDA's official safety alerts page, making it accessible to healthcare providers, pharmacists, and the general public. XD Investments LLC is responsible for managing the removal of all affected inventory from distribution channels. The company's cooperation with the FDA in executing the recall is standard protocol for voluntary market withdrawals of dietary supplement products that do not meet labeling requirements.

What the source says

Mitragynine is the primary psychoactive alkaloid found in kratom (Mitragyna speciosa), a tropical plant native to Southeast Asia. The compound acts as a partial mu-opioid receptor agonist and exhibits dose-dependent effects: stimulant-like properties at lower doses and sedative and analgesic effects at higher doses. Mitragynine pseudoindoxyl is a structural analog formed when mitragynine undergoes oxidation and may exhibit similar pharmacological activity.

Research indicates that kratom products containing these alkaloids can produce opioid-like withdrawal symptoms with chronic use, interact with medications metabolized by cytochrome P450 enzymes (including many common antidepressants, antihistamines, and blood pressure drugs), and carry potential for dependence. The FDA classifies undeclared active ingredients as a serious violation because consumers cannot make informed decisions about potential side effects, drug interactions, or contraindications.

Beyond the headline

The Better Weather Fix Elixir recall reflects a broader trend in the dietary supplement industry: some manufacturers market products with undeclared kratom alkaloids as dietary supplements to circumvent stricter drug approval pathways. Kratom products occupy a regulatory gray zone in the United States. The FDA has issued multiple warning letters to companies selling kratom-containing products and has proposed restrictions on kratom sales, but the compound remains legal to market as a dietary supplement in most states. This creates an incentive for some manufacturers to hide kratom content under vague proprietary blends or botanical names, obscuring the presence of mitragynine from consumers and healthcare providers.

Between 2020 and 2026, the FDA has intensified monitoring of botanical supplements that contain alkaloids with opioid-like, stimulant, or hallucinogenic properties. This enforcement surge follows congressional scrutiny regarding the safety of kratom products and reports of adverse events including seizures, liver injury, and opioid-like withdrawal symptoms linked to kratom use. The Better Weather Fix Elixir case demonstrates that voluntary disclosure and accurate labeling remain inconsistently applied across the supplement industry, creating ongoing public health challenges.

What this means for consumers

If you have purchased Better Weather Fix Elixir, stop using it immediately and return it to the retailer or manufacturer for a refund. Do not attempt to use up remaining doses.

If you have ingested this product and experience symptoms such as nausea, constipation, drowsiness, dizziness, or difficulty urinating, contact your healthcare provider and disclose the use of this specific product. Provide your provider with the batch number and date of purchase if available.

If you are taking opioid pain medications (such as tramadol, codeine, or prescription opioids), benzodiazepines (such as alprazolam or lorazepam), or sedating antidepressants (such as sertraline, paroxetine, or amitriptyline), you face elevated risk of dangerous drug interactions with undeclared mitragynine. Inform your pharmacist and physician immediately if you have used this product while taking these medications.

When purchasing dietary supplements, read labels carefully and verify complete ingredient lists that name specific botanical compounds by both common and scientific name. If a supplement label does not identify all active botanical ingredients clearly, contact the manufacturer for clarification before use. Be aware that kratom products are sometimes sold under alternative names or described vaguely as "herbal blends" or "botanical extracts." Consumers who prefer transparency and third-party verification may choose supplements that have undergone independent testing by organizations that verify ingredient identity and potency. If you are currently taking any kratom-containing product, inform your primary care physician and pharmacist of this use, particularly if you take any prescription medications.

What to watch next

The FDA will continue monitoring XD Investments LLC and other manufacturers for compliance with the recall and for future violations. Additional recalls of kratom-containing products mislabeled as dietary supplements are likely in the coming months as the agency increases enforcement activity. The FDA's ongoing efforts to restrict kratom marketing—including potential state-level restrictions on sales and further warning letters to non-compliant manufacturers—will shape how the supplement industry handles kratom-derived alkaloids.

Consumers should monitor the FDA's official recall database regularly for updates on Better Weather Fix Elixir and similar products, and stay informed about regulatory changes affecting kratom availability and labeling requirements in their state.